tiprankstipranks
Trending News
More News >
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market

Sunshine Biopharma (SBFM) Income Statement

Compare
407 Followers

Sunshine Biopharma Income Statement

Last quarter (Q4 2024), Sunshine Biopharma's total revenue was $9.59M, an increase of 24.93% from the same quarter last year. In Q4, Sunshine Biopharma's net income was $-2.16M. See Sunshine Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 34.87M$ 24.09M$ 4.35M$ 228.43K$ 71.41K
Gross Profit
$ 10.67M$ 8.34M$ 1.70M$ 110.60K$ 45.56K
Operating Expenses
$ 16.48M$ 13.12M$ 10.37M$ 2.55M$ 622.44K
Depreciation and Amortization
$ 223.53K$ 149.15K$ 25.16K$ 12.74K$ 14.07K
EBITDA
$ -5.15M$ -3.82M$ -26.45M$ -12.09M$ -2.60M
Operating Income
$ -5.81M$ -4.79M$ -8.67M$ -2.44M$ -576.87K
Other Income/Expenses
$ 443.15K$ 674.42K$ 489.61K$ -10.00M$ -2.21M
Pretax Income
$ -5.37M$ -4.11M$ -26.51M$ -12.44M$ -2.78M
Net Income
$ -5.13M$ -4.51M$ -26.74M$ -12.77M$ -897.68K
Per Share Metrics
Basic EPS
$ -7.32$ -370.41$ -3.52K$ -9.77K$ -1.04K
Diluted EPS
$ -7.32$ -370.41$ -3.52K$ -9.77K$ -1.04K
Weighted Average Shares Outstanding
701.75K 12.16K 7.59K 1.31K 866.00
Weighted Average Shares Outstanding (Diluted)
701.75K 12.16K 7.59K 1.31K 866.00
Currency in USD

Sunshine Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis